Merrimack's Prospects Dim As MM-141 Fails Pancreatic Cancer Phase II Trial

Pancreatic cancer
MM-141 Missed Endpoints In CARRIE Phase II Trial • Source: Shutterstock

More from Clinical Trials

More from R&D